Browsing “August, 2020 | EVERSANA”

Cadila Launches Adalimumab Biosimilar, Cadalimab in India

Country: INDIA | Region: ASIA & SOUTH PACIFIC | Type: Drug Launch | Keywords: #adalimumab #biosimilar #cadalimab #cadila #humira PRICENTRIC BRIEF: Cadila Pharmaceuticals has announced the launch of its adalimumab biosimilar, Cadalimab, referencing AbbVie’s blockbuster Humira, in India Cadalimab is available in 40mg/0.8ml injection and has shown to lead to a significant reduction in signs and symptoms of rheumatoid arthritis, juvenile idiopathic arthritis, […]

Workshop: How to Get Your Digital Therapeutic Approved & Reimbursed in Europe and the U.S.

September 10, 2020, at 2 PM BST | 9 AM EST – REGISTER NOW Patients, providers, and payers expect healthcare to be more accessible, intuitive, and adaptable to their needs. Barriers that have held back innovation in Digital Medicine and Telemedicine have been blasted apart with the recent relaxing of CMS and HHS requirements, continuing […]

Evoke Pharma and EVERSANA Announce the Appointment of Christopher Quesenberry as Chief Commercial Officer for Gimoti™

Gimoti commercial launch on track for the fourth quarter of 2020 SOLANA BEACH, Calif. and CHICAGO, Aug. 25, 2020 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases and EVERSANA™, a leading provider of global commercial services to the life science industry, today announced that EVERSANA has […]

Fiocruz Produces Breast Cancer Drug Trastuzumab for Brazil’s SUS

 Country: BRAZIL | Region: SOUTH AMERICA | Type: Pricing & Reimbursement | Keywords: #bio-manguinhos #breastcancer #fiocruz #oncology #sus #trastuzumab PRICENTRIC BRIEF: The Oswaldo Cruz Foundation is now supplying trastuzumab to the Ministry of Health (MoH), which distributes the drug to patients free of charge through the Brazilian Public Health System (SUS) to treat a subtype of breast cancer identified by the overexpression of the […]

Medicine Prices Remain Unchanged in Pakistan

Country: PAKISTAN | Region: ASIA & SOUTH PACIFIC | Type: Price Changes | Keywords: #covid19 #drap #drugpricingpolicy #drugshortages #essentialmedicines #nationalhealthservice #priceincreases PRICENTRIC BRIEF: The Ministry of National Health Services Regulation and Coordination (NHSR&C) allowed pharmaceutical companies to increase the prices of essential drugs by 7% and non-essential drugs by 10%, in accordance with the annual consumer price index (CPI) However, pharmaceutical companies decided against […]

Switzerland Introduces Confidential Managed-Entry Agreements, Cost-Containment Measures

Country: SWITZERLAND | Region: EUROPE | Type: Policy | Keywords: #aos #confidentiality #costcontainment #innovation #managedentryagreements #patientaccess #payforperformance #refunds #salesvolumelimits PRICENTRIC BRIEF: A new law from Switzerland’s Ministry of the Interior seeks to establish a legal basis for use of confidential market-access schemes to improve patient access to innovative medicines With 20 such contracts signed over the last year, Switzerland will henceforth continue to utilize […]

China Publishes Working Plan for 2020 NRDL Update, Revised List Expected December 2020

Country: CHINA | Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #basicmedicalinsurance #bidding #negotiations #nhsa #nmpa #nrdl #pricingandreimbursement PRICENTRIC BRIEF: The National Healthcare Security Administration (NHSA) of China has issued its official work plan for revisions to the 2020 National Reimbursed Drug List (NRDL), including application guidelines for revision of the list Some criteria for inclusion in the 2020 NRDL include: the drug must intend to treat […]

The Netherlands’ New IRP to Take Effect October 1

Country: NETHERLANDS | Region: EUROPE | Type: Reference Pricing (IRP) | Keywords: #covid19 #drugshortages #drugsupply #generics #hospitalmedicines #maximumprices #medicinespricingact #ministryofhealthwelfareandsport #policy #referencebasket #wgp PRICENTRIC BRIEF: The Netherlands will be implementing its new international reference pricing (IRP) rule from October 1, 2020; originally, the rule was supposed to take effect April 1 of this year Via the Medicines Pricing Act (WGP), maximum prices are […]

Pharma JAPAN 2020 (formerly eyeforpharma)

EVERSANA is proud to be a Global Sponsor at this year’s Pharma Japan 2020 (formerly eyeforpharma Japan), taking place on September 1-4. The healthcare landscape is evolving and pharma must evolve with it. From the Opening Keynote, focusing on the future direction of pharma with cutting-edge case studies, to the practical themes covering Digital Clinical Innovation, […]

Pharmaceutical Executive Virtual Conference

Pharmaceutical Executive’s Virtual Conference: Reaching the Healthcare Provider After COVID-19 THURSDAY, AUGUST 13 Jeff LaVaute, Managing Director of Market Access Strategy, and Taegan Grice, Managing Director of Creative 11:20-11:50 AM EST PRESENTATION: Lessons Learned for Engaging HCPs in the Virtual/COVID Environment. SUMMARY: This presentation will cover the way physicians consume medical information is evolving – […]